Serum melatonin levels following enucleation and transpupillary thermotherapy in patients with choroidal melanoma

被引:4
作者
Kiratli, H
Gedik, S
Us, D
Bilgiç, S
机构
[1] Hacettepe Univ, Sch Med, Dept Ophthalmol, Ocular Oncol Serv, Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Clin Biochem, Ankara, Turkey
关键词
choroidal melanoma; enucleation; melatonin; transpupillary thermotherapy;
D O I
10.1046/j.1442-9071.2003.00707.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study serum melatonin levels in patients with choroidal melanoma preoperatively and following enucleation and transpupillary thermotherapy. Methods: Forty patients with preoperative choroidal melanoma were included in the study. Of these, 15 patients underwent enucleation (group 1) and 25 patients received transpupillary thermotherapy (group 2). A further 20 patients without melanoma acted as age-matched controls. Serum melatonin levels were determined 1 day preoperatively, and at the first and sixth months postoperatively using ELISA. Results: Preoperative serum melatonin levels were highest in group 2 followed by group 1, but this was not statistically significant compared to controls. Postoperatively, a constant decrease of serum melatonin was observed in both groups after the first month, which reached statistical significance at the sixth month (P = 0.003). Also, a significant regression in tumour thickness was documented in group 2 (P = 0.003). Three patients in group 1 developed hepatic metastases. Conclusions: Patients with choroidal melanomas had higher levels of serum melatonin compared to individuals without tumours. Smaller tumours were associated with more elevated melatonin levels compared to larger tumours. Serum melatonin levels fell considerably following enucleation and transpupillary thermotherapy.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 20 条
  • [11] Commentary: What does melatonin do and how does it do it?
    Menaker, M
    [J]. JOURNAL OF BIOLOGICAL RHYTHMS, 1997, 12 (06) : 532 - 534
  • [12] MELATONIN - PERSPECTIVES IN LABORATORY MEDICINE AND CLINICAL RESEARCH
    MILES, A
    PHILBRICK, D
    [J]. CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1987, 25 (03): : 231 - 253
  • [13] MELATONIN RECEPTORS - LOCALIZATION, MOLECULAR PHARMACOLOGY AND PHYSIOLOGICAL SIGNIFICANCE
    MORGAN, PJ
    BARRETT, P
    HOWELL, HE
    HELLIWELL, R
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1994, 24 (02) : 101 - 146
  • [14] THE MAMMALIAN PINEAL-GLAND - STRUCTURE AND FUNCTION
    REITER, RJ
    [J]. AMERICAN JOURNAL OF ANATOMY, 1981, 162 (04): : 287 - 313
  • [15] Roberts JE, 2000, J PINEAL RES, V28, P165
  • [16] Rohrbach J. M., 1993, Ophthalmologe, V90, P289
  • [17] GROWTH INHIBITORY AND CYTO-TOXIC EFFECTS OF MELATONIN AND ITS METABOLITES ON HUMAN-TUMOR CELL-LINES INVITRO
    SHELLARD, SA
    WHELAN, RDH
    HILL, BT
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 288 - 290
  • [18] MELATONIN INHIBITS PROLIFERATION AND MELANOGENESIS IN RODENT MELANOMA-CELLS
    SLOMINSKI, A
    PRUSKI, D
    [J]. EXPERIMENTAL CELL RESEARCH, 1993, 206 (02) : 189 - 194
  • [19] MELATONIN - BINDING-SITE CHARACTERISTICS AND BIOCHEMICAL AND CELLULAR-RESPONSES
    SUGDEN, D
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1994, 24 (02) : 147 - 157
  • [20] HUMAN-MALIGNANT MELANOMA-CELLS EXPRESS HIGH-AFFINITY RECEPTORS FOR MELATONIN - ANTIPROLIFERATIVE EFFECTS OF MELATONIN AND 6-CHLOROMELATONIN
    YING, SW
    NILES, LP
    CROCKER, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 246 (02): : 89 - 96